Use of Whole Genome Sequencing for Mycobacterium tuberculosis Complex Antimicrobial Susceptibility Testing: From Sequence Data to Resistance Profiles

Methods Mol Biol. 2024:2833:195-210. doi: 10.1007/978-1-0716-3981-8_18.

Abstract

Whole genome sequencing of Mycobacterium tuberculosis complex (MTBC) isolates has been shown to provide accurate predictions for resistance and susceptibility for many first- and second-line anti-tuberculosis drugs. However, bioinformatic pipelines and mutation catalogs to predict antimicrobial resistances in MTBC isolates are often customized and detailed protocols are difficult to access. Here, we provide a step-by-step workflow for the processing and interpretation of short-read sequencing data and give an overview of available analysis pipelines.

Keywords: BioinformaticsBioinformatics pipeline; MutationMutations catalog; Mycobacterium tuberculosisMycobacterium tuberculosis (M. tuberculosis) complex; Resistance prediction.

MeSH terms

  • Antitubercular Agents* / pharmacology
  • Computational Biology* / methods
  • Drug Resistance, Bacterial / genetics
  • Genome, Bacterial
  • Humans
  • Microbial Sensitivity Tests* / methods
  • Mutation
  • Mycobacterium tuberculosis* / drug effects
  • Mycobacterium tuberculosis* / genetics
  • Tuberculosis / drug therapy
  • Tuberculosis / microbiology
  • Whole Genome Sequencing* / methods

Substances

  • Antitubercular Agents